eBook - ePub
Diagnosis and Management in Dementia
The Neuroscience of Dementia, Volume 1
This is a test
- 910 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Diagnosis and Management in Dementia
The Neuroscience of Dementia, Volume 1
Book details
Book preview
Table of contents
Citations
About This Book
Diagnosis and Management in Dementia: The Neuroscience of Dementia, Volume 1 consolidates different fields of dementia into a single book, covering a range of subjects, including Alzheimer's disease, Lewy body dementia, mixed dementia, vascular dementia, physical activity, risk factors, mortality, biomarkers, SPECT, CT, MRI, questionnaires, nutrition, sleep, delirium, hearing loss, agitation, aggression, delusions, anxiety, depression, hallucinations, psychosis, senile plaques, tau and amyloid-beta, neuroinflammation, molecular biology, and more. With an impact on millions globally, and billions of research dollars being invested in dementia research, this book will stimulate research in the area and inform researchers.
- Offers comprehensive coverage of a broad range of topics related to dementia
- Serves as a foundational collection for neuroscientists and neurologists on the biology of dementia and brain dysfunction
- Contains in each chapter an abstract, key facts, mini dictionary of terms, and summary points to aid in understanding
- Provides unique sections on specific subareas, intellectual components, and knowledge-based niches that will help readers navigate key areas for research and further clinical recommendations
- Features preclinical and clinical studies to help researchers map out key areas for research and further clinical recommendations
- Serves as a "one-stop" source for everything you need to know about dementia
Frequently asked questions
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlegoâs features. The only differences are the price and subscription period: With the annual plan youâll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, weâve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access Diagnosis and Management in Dementia by Colin R Martin,Victor R Preedy in PDF and/or ePUB format, as well as other popular books in Medicine & Physiology. We have over one million books available in our catalogue for you to explore.
Information
Topic
MedicineSubtopic
PhysiologyPart I
Dementia: introductory chapters and setting the scene
Chapter 1
Mixed dementia
a neuropathological overview
Jacques De Reuck Degenerative & vascular cognitive disorders. Lille, France
Abstract
The definitive diagnosis of mixed dementias can be made only by an extensive neuropathological examination. These diseases are mainly observed in elderly patients and further increase during the aging process even when they started as a single illness. They are for 85% of patients due to a combination of Alzheimer, Lewy body, and vascular pathology. The last can be due to cerebral amyloid angiopathy or arteriosclerotic cerebrovascular disease. However, some neurodegenerative diseases remain mainly unmixed, such as frontotemporal lobar degeneration, amyotrophic lateral sclerosis, progressive supranuclear palsy, and corticobasal degeneration. This can mainly be explained by the favorable vascular profile of the patients with these diseases. The clinical diagnosis of most mixed neurodegenerative and cerebrovascular dementia diseases can be suspected by means of magnetic resonance imaging and positron emission tomography of the brain, using glucose, amyloid, and tau tracers.
Keywords
7.0-tesla magnetic resonance imaging; Alzheimer pathology; Amyotrophic lateral sclerosis; Corticobasal degeneration; Frontotemporal lobar degeneration; Lewy body pathology; Mixed dementia; Neuropathology; Progressive supranuclear palsy; Unmixed dementia
List of abbreviations
AD Alzheimer disease
ALS amyotrophic lateral sclerosis
CAA cerebral amyloid angiopathy
CBD corticobasal degeneration
CoMBs cortical microbleeds
CoMIs cortical microinfarcts
FTLD frontotemporal lobar degeneration
FUS type fused sarcoma type
LBD Lewy body disease
MRI magnetic resonance imaging
PET positron emission tomography
PSP progressive supranuclear paralysis
TDP type TAR DNA-binding protein type
VaD vascular dementia
WMCs white matter changes
Mini-dictionary of terms
Mixed dementia severe cognitive deficiency due to a combination of different neurodegenerative and/or cerebrovascular diseases.
Neuropathological examination postmortem evaluation of the brain to confirm the clinical suspected diagnosis.
Postmortem MRI this allows the detection of additional postmortem brain lesions, in particular the distribution of small cerebrovascular lesions, and the iron content.
Neurodegenerative diseases progressive diffuse diseases affecting mainly neurons, leading to a global cerebral dysfunction.
Vascular dementia severe cognitive disturbances due to the progressive accumulation of small and large cerebrovascular lesions.
Introduction
The etiological diagnosis of mixed dementia diseases can be made with certainty only after death by an extensive examination of the brain (Jellinger & Attems, 2007). According to several clinicopathological surveys, the main clinical diagnosis is confirmed in 43% up to 86% of cases by the neuropathological evaluation (Suemoto et al., 2017). This correlation has increased significantly from 65% up to 96% since the development of new biomarkers such as magnetic resonance imaging (MRI), positron emission tomography (PET), cerebrospinal fluid analysis, and genetic markers (Jellinger, 2009).
In the Lille Memory Clinic the clinical diagnosis of Alzheimer disease (AD) is confirmed in 94% of the cases, Lewy body disease (LBD) in 80%, vascular dementia (VaD) in 100%, and mixed ADâVaD in 93% by the neuropathological examination (Bombois et al., 2008). Early previously obtained informed consent from the patients themselves or later from the nearest family allows the autopsy for diagnostic and scientific purposes. The brain tissue samples are acquired from the Neuro-Bank of Lille University, federated to the Centre des Resources Biologiques, which acts as an institutional review board.
The standard procedure for the neuropathological diagnosis of the dementia types consists of examining samples from the primary motor cortex; the associated frontal, temporal, and parietal cortices; the primary and secondary visual cortex; the cingulate gyrus; the basal nucleus of Meynert; the amygdaloid body; the hippocampus; the basal ganglia; the mesencephalon; the pons; the medulla; and the cerebellum. The slides from paraffin-embedded sections are stained with hematoxylinâeosin, Luxol fast blue, and Prussian Perl. In addition, immunostaining for protein tau, β-amyloid, Îą-synuclein, prion protein, TDP-43, and ubiquitin is performed (De Reuck, 2012a). Fused sarcoma (FUS) histochemistry is carried out in the cases of frontotemporal lobar degeneration (FTLD) that are tau and TDP-43 negative (De Reuck et al., 2016d). In addition, small cerebrovascular lesions can be quantified on microscopical examination of a large complete coronal section of a cerebral hemisphere at the level of the mammillary body.
Postmortem 7.0-tesla MRI is an additional useful tool. Three to six coronal sections of a cer...
Table of contents
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- Contributors
- Foreword
- Preface
- Part I. Dementia: introductory chapters and setting the scene
- Part II. Biomarkers, psychometric instruments and diagnosis
- Part III. Pharmacological treatments for dementia
- Part IV. Non-pharmacological treatments and procedures
- Index